Sexual Health Impact of Using Pre-exposure HIV Prophylaxis
NCT ID: NCT05269199
Last Updated: 2023-05-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
56 participants
OBSERVATIONAL
2022-04-01
2023-03-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sexual Risks in Prep Users
NCT03975517
Predictors of Health Service Utilizations Among Key Population in Washington DC
NCT06046079
Quality of Sexual Life of PrEP Users
NCT06286527
Missed Opportunities to Pre-exposure Prophylaxis for HIV Infection on Person Newly Diagnosed With HIV
NCT03671291
Sexual Needs of Adolescents Living With HIV Since Childhood
NCT05206123
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to give his non-opposition to participate in the research.
* Affiliation to a social security scheme.
Exclusion Criteria
* Refusal to participate
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Clermont-Ferrand
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CH Brioude
Brioude, , France
CEGIDD Clermont Ferrand
Clermont-Ferrand, , France
CHU Clermont-Ferrand
Clermont-Ferrand, , France
CH Le Puy en Velay
Le Puy-en-Velay, , France
CH Montluçon
Montluçon, , France
CH Moulins
Moulins, , France
CH Vichy
Vichy, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RNI 2021 JACOMET
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.